Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for XRAY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 99.00M
March 31, 2026 40.00M
December 31, 2025 101.00M
September 30, 2025 79.00M
June 30, 2025 48.00M
March 31, 2025 7.00M
December 31, 2024 87.00M
September 30, 2024 141.00M
June 30, 2024 208.00M
March 31, 2024 25.00M
December 31, 2023 160.00M
September 30, 2023 134.00M
June 30, 2023 104.00M
March 31, 2023 -21.00M
December 31, 2022 142.00M
September 30, 2022 109.00M
June 30, 2022 173.00M
March 31, 2022 93.00M
December 31, 2021 222.00M
September 30, 2021 172.00M
June 30, 2021 214.00M
March 31, 2021 49.00M
December 31, 2020 250.00M
September 30, 2020 220.60M
June 30, 2020 175.10M
Date Value
March 31, 2020 -10.70M
December 31, 2019 299.30M
September 30, 2019 159.10M
June 30, 2019 145.10M
March 31, 2019 29.30M
December 31, 2018 202.20M
September 30, 2018 125.60M
June 30, 2018 116.90M
March 31, 2018 55.10M
December 31, 2017 228.90M
September 30, 2017 164.30M
June 30, 2017 126.20M
March 31, 2017 82.50M
December 31, 2016 222.40M
September 30, 2016 152.90M
June 30, 2016 187.40M
March 31, 2016 0.70M
December 31, 2015 126.40M
September 30, 2015 159.76M
June 30, 2015 145.61M
March 31, 2015 65.63M
December 31, 2014 192.62M
September 30, 2014 147.54M
June 30, 2014 155.68M
March 31, 2014 64.56M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Align Technology, Inc. 192.76M
Envista Holdings Corp. 119.20M
Milestone Scientific, Inc. -0.5851M
Sonendo, Inc. --
Integra LifeSciences Holdings Corp. 22.80M